Shares of Indivior PLC (LON:INDV – Get Free Report) passed above its 50-day moving average during trading on Tuesday. The stock has a 50-day moving average of GBX 1,238 and traded as high as GBX 1,264. Indivior shares last traded at GBX 1,238, with a volume of 8,457,898 shares trading hands.
Indivior Trading Up 1.6%
The company has a market cap of £1.93 billion, a PE ratio of -1,026.48, a price-to-earnings-growth ratio of -5.57 and a beta of 0.19. The company has a quick ratio of 1.52, a current ratio of 0.89 and a debt-to-equity ratio of -107.76. The business has a 50-day simple moving average of GBX 1,238 and a 200-day simple moving average of GBX 1,238.
About Indivior
Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose. Its core marketed products include SUBLOCADE and SUBUTEX PRO buprenorphine extended-release monthly injections; SUBOXONE, a buprenorphine and naloxone sublingual film; SUBOXONE, a buprenorphine and naloxone sublingual tablet; and SUBUTEX, a buprenorphine sublingual tablet for the treatment of opioid use disorder.
Recommended Stories
- Five stocks we like better than Indivior
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Indivior Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Indivior and related companies with MarketBeat.com's FREE daily email newsletter.
